Erratum: A phase 2 randomized, double-blind, placebo-controlled study of the safety and efficacy of talactoferrin in patients with severe sepsis

Alejandro Arroliga, Robert Balk, Chad Cannon, Nathan Dean, Phillip Dellinger, Paula Dennen, Juan Figueroa, Eugene Fletcher, Kalpalatha K. Guntupalli, David T. Huang, Mitchell Levy, Takkin Lo, Imrana Malik, Benjamin Margolis, George Matuschak, Laura Moore, Gregory J. Moran, Eugene Moretti, Peter Morris, Edward PanacekEmanual Rivers, Greg Schmidt, Michael G. Seneff, Jay Steingrub, Robert Taylor

Research output: Contribution to journalComment/debate

Fingerprint

Dive into the research topics of 'Erratum: A phase 2 randomized, double-blind, placebo-controlled study of the safety and efficacy of talactoferrin in patients with severe sepsis'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science